Explore News By Topic
08/10/2017
Statistical Shortcut Could Speed Evaluation of Prostate Cancer Drugs
Clinical trials of adjuvant therapies used in treating some men with prostate cancer could be completed more quickly by using a “surrogate” endpoint, scientists report The investigators found that metastasis-free survival – how long patients survived without the cancer spreading – was a strong predictor of their overall survival BOSTON,... Read More
08/04/2017
Researchers make mathematical crystal ball to gaze into future of prostate cancer treatment
Aurora, CO, August 4, 2017 - The chemotherapy docetaxel is widely accepted as a standard therapy for metastatic castration-resistant prostate cancer. But 10-20 percent of patients will have adverse side effects that force discontinuation of treatment. These patients may have been better off with another treatment or alternative dosing of docetaxel... Read More
08/02/2017
Comprehensive sequencing program shows promise of precision medicine for advanced cancer
ANN ARBOR, Michigan, August 2, 2017 — The average metastatic cancer has more genetic mutations than are seen in early stage tumors, a new study finds. What that means: To make precision medicine a reality in cancer care, you need a real-time, comprehensive approach that looks at the metastatic tumors... Read More
07/10/2017
Prostate Cancer Foundation Announces 2017 Young Investigator Award Recipients
SANTA MONICA, CA, July 10, 2017 -- The Prostate Cancer Foundation (PCF) today announced its 2017 Young Investigator (YI) Awards, which support early career scientists who are focused on accelerating the delivery of life-extending and life-saving therapies for men living with prostate cancer. The YI Awards provide three years of... Read More
07/07/2017
Precision medicine study finds new treatment for untreatable subtype of advanced prostate cancer
A clinical trial reported on at the 2017 American Society of Clinical Oncology (ACSO) Annual Meeting found that advanced prostate cancer patients whose tumors have a certain combination of mutations may significantly benefit from treatment with platinum chemotherapy. Not all “chemotherapy” is the same. Taxane chemotherapy (docetaxel, cabazitaxel) which works... Read More
06/29/2017
Combination of two new therapies may be highly effective in advanced prostate cancer
Early results from a clinical trial presented at the 2017 American Society of Clinical Oncology (ACSO) Annual Meeting found that combining an immunotherapy with a targeted therapy may be highly effective in patients with advanced prostate cancer. Checkpoint immunotherapy, a treatment that reboots hibernating tumor-killing immune cells, has produced remarkable,... Read More
06/21/2017
Immunotherapy and Prostate Cancer
Part I Part II Part III A Vaccine for Prostate Cancer Who's Who in the Immune System Immunotherapy and Prostate Cancer Checkpoint Inhibitors Miracle Drugs for Some, But Not Yet All Checkpoint inhibitors have one mission: to wake up the sleeping T cells, and in some people with cancer, they... Read More
06/20/2017
Immunotherapy: Who’s Who in the Immune System
Part I Part II Part III A Vaccine for Prostate Cancer Who's Who in the Immune System Immunotherapy and Prostate Cancer Making sense of some very complicated stuff only a few scientists truly understand: A guide to the immune system for the rest of us. Let’s think of the... Read More
New three-in-one blood test opens door to precision medicine for prostate cancer
Test picks out men for treatment, detects early signs of resistance and monitors cancer’s evolution over time Advance is part of strategic push to overcome cancer evolution and drug resistance LONDON, June 18, 2017 - Scientists have developed a three-in-one blood test that could transform treatment of advanced prostate... Read More
06/15/2017
Immunotherapy: A Vaccine for Prostate Cancer
https://vimeo.com/731870460/f451d6b79c In this three part series, we examine the latest advances in immunotherapy, one of the most promising strategies in cutting edge cancer research, and it's affects on prostate cancer treatment. Part I Part II Part III A Vaccine for Prostate Cancer Who's Who in the Immune System Immunotherapy... Read More